Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$8.75 - $15.49 $108,631 - $192,308
-12,415 Closed
0 $0
Q4 2020

Feb 10, 2021

SELL
$7.11 - $9.99 $52,507 - $73,776
-7,385 Reduced 37.3%
12,415 $122,000
Q3 2020

Nov 13, 2020

SELL
$7.15 - $8.73 $158,629 - $193,683
-22,186 Reduced 52.84%
19,800 $143,000
Q2 2020

Aug 13, 2020

BUY
$6.15 - $9.4 $68,486 - $104,678
11,136 Added 36.1%
41,986 $376,000
Q1 2020

May 14, 2020

BUY
$5.88 - $15.75 $93,239 - $249,747
15,857 Added 105.76%
30,850 $218,000
Q4 2019

Feb 13, 2020

SELL
$7.5 - $17.15 $57,262 - $130,940
-7,635 Reduced 33.74%
14,993 $257,000
Q3 2019

Nov 13, 2019

BUY
$7.7 - $10.48 $174,235 - $237,141
22,628 New
22,628 $203,000

Others Institutions Holding SLGL

About Sol-Gel Technologies Ltd.


  • Ticker SLGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,129,500
  • Market Cap $12.5M
  • Description
  • Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...
More about SLGL
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.